Sun Pharmaceutical and Almirall which is a Spanish firm have entered into a licencing agreement for development and commercialisation of tildrakizumab which is used to...
A licensing arrangement has been entered between Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma for its Elepsia tablets that are used...
A rollout of Gemcitabine InfuSMART which is used in the treatment of cancer, in Europe, has been announced by Sun Pharmaceutical Industries. The company has...